Delivery Order SPE2DB22D3004-SPE2DB24FND43
Award Date 10/11/23
Potential Completion Date 10/12/23
Potential Value $27K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $1,535.60 with a Firm Fixed Price pricing type and an ultimate completion date of September 28, 2023. The contract is for the delivery of Mycophenolic Acid delayed-release tablets, 360mg, in quantities of 120s. This pharmaceutical product is likely used to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a firm fixed price delivery order, is for the supply of Mycophenolate 500 mg tablets. The contract has a ceiling value of $2,073.55 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mycophenolate 500 mg tablets. The firm-fixed-price delivery order has a ceiling value of $2,991.75 and a period of performance through April 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,858.07 firm fixed-price delivery order is for the supply of Mycophenolate 200 mg/ml suspension, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order valued at $5,439.13, is for the supply of 100-count bottles of the drug Mycophenolate 500 mg tablets. The contract has an ultimate completion date of July 14, 2025 and utilizes a Firm Fixed Price pricing type. This award is not a set-aside contract. Amerisourcebergen Drug Corp is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,162.68 Firm Fixed Price Delivery Order is for the supply of 4,564,803,594 units of Mycophenolate 500 mg tablets. The contract has an ultimate completion date of June 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $6,776.92, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Mycophenolate 200 mg/ml suspension, a pharmaceutical product, with a completion date of December 5, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award was made through full and open competition, as there was no set-aside designation....
- The Defense Logistics Agency awarded a delivery order valued at $1,027.72 to AmerisourceBergen Drug Corp for the supply of Mycophenolic Acid delayed-release 360 milligram tablets (120-count bottles). The contract is a firm fixed-price delivery order with an ultimate completion date of February 5, 2026, and was awarded on February 4, 2026, with no set-aside designation. Performance will occur at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is executed under the parent...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,331.60, is for the delivery of Mycophenolate 500 mg tablets. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $2,895.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Mycophenolate 200 mg/ml suspension, a pharmaceutical product, to support military treatment facilities and other government healthcare programs. The contract is a delivery order (SPE2DB20D1100|SPE2DB24FZ70X) with a firm fixed price pricing type, and it has an ultimate completion date of January 16,...